{
    "organizations": [],
    "uuid": "024019580ebce44334d9eed54f37e36f5d2d9431",
    "author": "",
    "url": "https://www.reuters.com/article/brief-quest-pharmatech-unit-sign-license/brief-quest-pharmatech-unit-sign-license-agreement-with-stanford-university-idUSFWN1OY0DI",
    "ord_in_thread": 0,
    "title": "BRIEF-Quest Pharmatech Unit Sign License Agreement With Stanford University",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "January 3, 2018 / 2:33 PM / in 12 minutes BRIEF-Quest Pharmatech Unit Sign License Agreement With Stanford University Reuters Staff 1 Min Read \nJan 3 (Reuters) - Quest Pharmatech Inc: \n* QUEST PHARMATECH- UNIT SIGN EXCLUSIVE LICENSE AGREEMENT WITH STANFORD UNIVERSITY TO DEVELOP & COMMERCIALIZE PATENTED EGF WOUND HEALING TECHNOLOGY Source text for Eikon: Further company coverage:",
    "published": "2018-01-03T16:33:00.000+02:00",
    "crawled": "2018-01-03T17:00:48.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "january",
        "pm",
        "minute",
        "pharmatech",
        "unit",
        "sign",
        "license",
        "agreement",
        "stanford",
        "university",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "quest",
        "pharmatech",
        "inc",
        "quest",
        "unit",
        "sign",
        "exclusive",
        "license",
        "agreement",
        "stanford",
        "university",
        "develop",
        "commercialize",
        "patented",
        "egf",
        "wound",
        "healing",
        "technology",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}